Leuprolide

( DrugBank: Leuprolide / KEGG DRUG: Leuprolide acetate, Leuprolide, Leuprolide mesylate )

---

5 diseases

1. 球脊髄性筋萎縮症

---

臨床試験数 : 20 / 薬物数 : 19 - (DrugBank : 8) / 標的遺伝子数 : 11 - 標的パスウェイ数 : 20 

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries

2. 筋萎縮性側索硬化症

---

臨床試験数 : 867 / 薬物数 : 820 - (DrugBank : 185) / 標的遺伝子数 : 189 - 標的パスウェイ数 : 237 

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries

3. 脊髄性筋萎縮症

---

臨床試験数 : 317 / 薬物数 : 217 - (DrugBank : 34) / 標的遺伝子数 : 55 - 標的パスウェイ数 : 79 

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries

51. 全身性強皮症

---

臨床試験数 : 740 / 薬物数 : 813 - (DrugBank : 165) / 標的遺伝子数 : 140 - 標的パスウェイ数 : 231 

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries

76. 下垂体性ゴナドトロピン分泌亢進症

---

臨床試験数 : 41 / 薬物数 : 46 - (DrugBank : 11) / 標的遺伝子数 : 5 - 標的パスウェイ数 : 15 

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries